Endolymphatic mastoid shunt for Menière's disease: do results change over time?
In 1983, results of a 5-year study using the endolymphatic mastoid shunt for treatment of Menière's disease were reported. Forty-eight patients were followed for between 1 and 5 years postoperatively, and 81% obtained satisfactory relief of vertigo. In the present analysis, 24 of these patients responded to a questionnaire, participated in a direct interview, and completed audiometric evaluations at 7 to 11 years after surgery. Eighty-three percent of these patients reported satisfactory relief of their vertigo. Results for hearing, tinnitus, and limitation of activities also varied little between the initial study and this longer-term follow-up. Studies with shorter follow-up appear valid in predicting longer-term results. These findings support the American Academy of Otolaryngology-Head and Neck Surgery's recommendation of a 2-year follow-up period for reporting results of therapy for Menière's disease.
Goldenberg
R A
RA
Department of Otolaryngology, School of Medicine, Wright State University, Dayton, Ohio.
Justus
M A
MA
D000328:Adult; D000368:Aged; D004713:Endolymphatic Shunt; D005260:Female; D005500:Follow-Up Studies; D006309:Hearing; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D008875:Middle Aged; D011183:Postoperative Complications; D014012:Tinnitus / Q000209:etiology; D014717:Vertigo / Q000209:etiology